Fibroblast growth factors (FGF) are involved in paracrine signaling between cell types in the ovarian follicle. FGF8, for example, is secreted by oocytes and controls cumulus cell metabolism. The closely related FGF18 is also expressed in oocytes in mice. The objective of this study was to assess the potential role of FGF18 in follicle growth in a monovulatory species, the cow. Messenger RNA encoding FGF18 was detected primarily in theca cells, and in contrast to the mouse, FGF18 was not detected in bovine oocytes. Addition of FGF18 protein to granulosa cell cultures inhibited estradiol and progesterone secretion as well as the abundance of mRNA encoding steroidogenic enzymes and the follicle-stimulating hormone receptor. In vivo, onset of atresia of the subordinate follicle was associated with increased thecal FGF18 mRNA levels and FGF18 protein in follicular fluid. In vitro, FGF18 altered cell cycle progression as measured by flow cytometry, resulting in increased numbers of dead cells (sub-G1 peak) and decreased cells in S phase. This was accompanied by decreased levels of mRNA encoding the cell cycle checkpoint regulator GADD45B. Collectively, these data point to a unique role for this FGF in signaling from theca cells to granulosa cells and suggest that FGF18 influences the process of atresia in ovarian follicles.
INTRODUCTION
There is mounting evidence that fibroblast growth factors (FGFs) are involved in ovarian function. There are 22 known FGFs classed into 7 subfamilies [1] , most of which act through transmembrane receptors (FGFR). Fibroblast growth factors are most famously known for their critical roles in organogenesis in the developing embryo [2] . In the reproductive system, FGF2, FGF9, and FGF18 play roles in gonadal development and sex differentiation [3] [4] [5] .
Fibroblast growth factors may also be important for paracrine signaling in the ovarian follicle, as the ligand tends to be expressed predominantly in one cell type and its receptor in another cell type. For example, FGF7 and FGF10 genes, which belong to one FGF subfamily, are expressed predominantly in theca cells and their main receptor, the b splice variant of FGFR2, is located on granulosa cells [6, 7] . Both FGF7 and FGF10 proteins inhibit estradiol secretion from granulosa cells [7, 8] . FGF9 is also expressed predominantly in theca cells and stimulates progesterone secretion from granulosa cells [9] .
Another FGF of considerable interest for follicle development is FGF8. In adult mice, gene expression occurs almost exclusively in the oocyte [10] , although in cattle, its mRNA is detected in theca and granulosa cells as well as in oocytes [11] . FGF8 activates the c splice variants of FGFR2 and FGFR3 [12] , and in mice, FGF8 cooperates with bone morphogenetic protein 15 (BMP15) to stimulate cumulus cell glycolysis [13] . FGF8 is the prototype of a subfamily containing FGF17 and FGF18, and ovarian FGF17 mRNA is restricted mainly to the oocyte [14] . In the mouse, Fgf18 expression is reported to be higher than that of Fgf17 [15] , suggesting that FGF18 is a potential oocyte-derived regulator of granulosa cell function. However, there are no other reports describing localization or action of FGF18 in the ovary.
The objective of the present study was to gain insight into the potential role of FGF18 in follicle development by determining the pattern of expression of FGF18 mRNA in the ovary during follicle growth in cattle and exploring the action of FGF18 on granulosa cells in a nonluteinizing serumfree culture system.
MATERIALS AND METHODS

Tissues and Cell Culture
Antral follicles were obtained from the ovaries of adult cows collected irrespective of the stage of estrous cycle from a local abattoir. Follicles of 5 mm and greater in diameter were dissected from the ovaries, and follicular fluid was aspirated, centrifuged, and frozen for progesterone and estradiol assay. The antral cavity was flushed repeatedly with cold saline, and granulosa cells were recovered by centrifugation at 1200 3 g for 1 min and pooled with the follicular fluid pellet. The remaining granulosa cells adhering to the follicle wall were removed by gently scraping with a blunt Pasteur pipette, and the theca layer were removed with forceps and washed in saline by passing repeatedly through a 1-ml syringe. The samples were collected into Trizol (Invitrogen, Carlsbad, CA) and homogenized with a Polytron (Brinkmann, Mississauga, ON, Canada). Total RNA was extracted immediately according to the Trizol protocol. Follicles were classed according to estradiol:progesterone (E2:P) ratios of .1, 1-0.01, and ,0.01 [16] , which we defined as healthy, transitional, and highly atretic, respectively [17] , and by size (5-7, 8-10, and .10 mm diameter). Cross-contamination of theca and granulosa cells was tested by detection of mRNA encoding cytochromes P450 aromatase (CYP19A1) and 17a-hydroxylase (CYP17A1) in each sample by PCR as described [11] . The presence of CYP19A1 amplicons in theca samples or of CYP17A1 in granulosa samples indicated cross-contamination, and such samples were discarded.
Cumulus-oocyte complexes (COC) were obtained for gene expression analyses by aspiration from follicles 2 to 5 mm in diameter, and were graded according to Leibfried and First [18] . Removal of cumulus cells was performed by vortexing the COCs. For achieving zona pellucida (ZP) digestion, the denuded oocytes were exposed to 0.5% pronase solution in phosphate-buffered saline (PBS; Sigma-Aldrich, Oakville, ON, Canada) for up to 10 min or to complete ZP dissolution. Three pools each of intact COCs, denuded oocytes, and cumulus cells were used, containing .40 COCs per pool.
The granulosa cell culture was based on the culture system described by Gutiérrez et al. [19] with slight modifications, that is, it is a serum-free culture that maintains an estrogenic phenotype with a minimum of luteinization [20] . The reagents were obtained from Invitrogen except where otherwise stated. Briefly, follicles between 2 and 5 mm in diameter were bisected, and cells were collected by rinsing the follicle walls with Dulbecco Modified Eagle medium/ F12 (DMEM/F12). A viable cell count was performed in the presence of 0.4% trypan blue, and 1 3 10 6 viable cells/ml were cultured in 24-well plates in DMEM/F12 with added sodium bicarbonate (10 mM), sodium selenite (4 ng/ ml), bovine serum albumin (0.1%; Sigma-Aldrich), penicillin (100 U/ml), streptomycin (100 lg/ml), transferrin (2.5 lg/ml), nonessential amino acid mix (1.1 mM), androstenedione (10 À7 M at start of culture, and 10 À6 M at each medium change), and bovine insulin (10 ng/ml). Cultures were maintained at 378C in 5% CO 2 in air for 6 days, with 700 ll of medium being replaced every 2 days.
Serum-free theca cell cultures were performed according to Campbell et al. [21] . Theca shells were removed from 2-to 5-mm follicles with forceps, washed in saline, and dispersed by incubation with collagenase II, protease, and hyaluronidase (1 mg/ml; Sigma-Aldrich) in PBS for 1 h at 378C. After 30 min of digestion, 100 units (U) DNase (Promega, Madison, WI) were added to the digestion mixture. Cells were cultured in DMEM/F12 as described for granulosa cells except that no androstenedione was added to the medium.
To assess hormonal regulation of FGF18 mRNA abundance, theca cells were cultured with graded doses of luteinizing hormone (LH; NIDDK [National Institute of Diabetes, Digestive, and Kidney Diseases]: AFP-11743B), and granulosa cells were cultured with graded doses (0, 0.1, 1, 10, 100 ng/ml) of follicle-stimulating hormone (FSH; NIDDK: AFP-5332B) or graded doses (0, 5, 50, 100 ng/ml) of insulin-like growth factor 1 (IGF1) analog (IGF1 long R3 [LR3], Sigma-Aldrich). These doses of FSH and IGF1 have been shown to stimulate estradiol secretion in this cell culture system [19, 22, 23] .
To determine the potential role of FGF18, granulosa cells were treated with FSH (10 ng/ml) to stimulate FGFR3 mRNA concentration [11] and with graded doses (0, 1, 10, and 100 ng/ml) of FGF18 (PeproTech, Rocky Hill, NJ) starting on Day 2 of culture. The doses used were based on the effective range of FGF10 and FGF17 in our hands [8, 14] . To measure steroid secretion, the medium was removed for steroid assay on Day 6 and stored at À208C. The cells were lysed with 200 ll of 1 N NaOH for 2 h followed by neutralization with 200 ll of 1 N HCl for total cell protein measurement with the Bradford protein assay (Bio-Rad, Mississauga, ON, Canada). To measure mRNA abundance, cells were collected into Trizol and stored at À808C until RNA extraction. The series of cultures were performed on at least three different pools of cells collected on different occasions.
The effect of FGF18 on cell proliferation was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay (R&D Systems, Minneapolis, MN) on Day 6 of culture; this assay measures the number of live cells. Cell cycle progression was measured by flow cytometry as described [24] . A minimum of 25 000 propidium iodide-stained cells/sample were sorted on a FACSVantage SE flow cytometer (BD Biosciences, Oakville, ON, Canada) and analyzed with Cell Quest Pro software (BD Biosciences). DNA fragmentation was assessed on Day 6 by extracting DNA with Trizol and analyzing DNA size by electrophoresis on 2% agarose gels.
Animals
The experimental animals were obtained from a herd of Angus cattle on a farm in the state of Rio Grande do Sul, Brazil. The experimental procedures were approved by the Federal University of Santa Maria Animal Care and Use Committee. Ovulation and subsequent emergence of the first follicle wave of the cycle were induced by an injection of prostaglandin F2a as described [25] . Between Days 2 and 4 of the cycle, when the newly selected dominant follicle can be identified by estradiol content but not necessarily by size [25, 26] , the animals were slaughtered at a local abattoir and the ovaries transported to the laboratory.
The two largest follicles were dissected from each pair of ovaries, their diameters were measured, and the follicular fluid was aspirated, centrifuged, and frozen for steroid assay. The antral cavity was repeatedly flushed with cold saline solution and granulosa cells recovered by centrifugation at 1200 3 g for 1 min and pooled with the follicular fluid pellet. The theca cell layer was then removed with forceps and washed in saline by passing repeatedly through a 1-ml syringe. The samples were collected into Trizol (Invitrogen, Burlington, ON, Canada), and the total RNA was extracted immediately according to the manufacturer's protocol. The dominant follicle in each animal was identified by follicular fluid estradiol concentration and evaluation of mRNA encoding CYP19A1 in granulosa cells. Contamination of theca cells with granulosa cells was determined by PCR for CYP19A1, and the one animal that showed contamination was not used in the analysis. Five animals were obtained that had readily identifiable dominant follicles based on estradiol and CYP19A1 mRNA levels but not based on follicle size alone.
Immunohistochemistry
Bovine ovaries were collected from an abattoir, bisected, and fixed in paraformaldehyde. Fixed tissues were embedded in paraffin, and 3-lm sections were placed on poly-L-lysine-coated slides. Sections were deparaffinized in xylene twice for 20 min, and hydrated in successive 3-min washes in 95% and 85% ethanol. Antigen retrieval was achieved by incubating in 0.5 M Trisethylenediaminetetraacetic acid, pH 9.0, at 968C for 30 min. Endogenous peroxidase was quenched by incubation in 5% hydrogen peroxide in methanol for 10 min, then rinsed 10 times in distilled water and twice for 5 min in 0.5 M Tris, pH 7.4. A goat polyclonal FGF18 antibody (SC-16830; Santa Cruz BioTechnology, Campinas, Brazil) was biotinylated (EZ-Link; Pierce Biotechnology, Rockford, IL) and incubated with tissues at 1:50 for 2 h at room temperature, followed by washing and incubation with avidin-peroxidase for 30 min (Vecstain ABC; Vector Laboratories, São Paulo, Brazil). Immunostaining was revealed with liquid 3,3 0 -diaminobenzidine (Dako, Carpinteria, CA). Negative controls were performed by preincubating FGF18 antibody with 4X blocking peptide (SC-16830P; Santa Cruz BioTechnology, Campinas, Brazil). Sections were counterstained with hematoxylin and eosin.
Western Blot Analysis
FGF18 protein abundance was assessed in follicular fluid by Western blot analysis. Samples were subjected to 12% denaturing PAGE and electrotransfered onto nitrocellulose membranes. After blocking for 1 h in 0.2% Tween-Tris-buffered saline (TBS), blots were incubated with 1:2000 mouse anti-human FGF18 (H00008817-B01P; Novus Biologicals, Inc., Littleton, CO) for 2 h with agitation, followed by three washes with 0.2% Tween-TBS. The blots were then incubated with 1:20 000 anti-mouse-HRP (horseradish peroxidase) (402335; Calbiochem, San Diego, CA) for 1 h with agitation, followed by three washes with 0.2% Tween-TBS. Finally, the blots were incubated in Immobilon Western Chemiluminescent HRP (Millipore, Billerica, MA) for 5 min and exposed to x-ray film for image analysis.
Serine protease inhibitor-E2 (SERPINE2, also known as protease nexin-1) is secreted by granulosa and not theca cells, and has been correlated with follicle health in cattle [27] . We therefore measured the effects of FGF18 on the secretion of this protein from cultured granulosa cells by Western blots in spent culture medium as described [28] . Media samples were concentrated by lyophilization, and the volume analyzed was adjusted to correct for cell number. Equal loading of proteins was assessed visually by Ponceau staining.
Real-Time PCR
For both in vivo and in vitro samples, gene expression was assessed by relative real-time PCR. Total RNA (1 lg) was first treated with 1 U DNase (Invitrogen) to digest any contaminating DNA. The RNA was reverse transcribed in the presence of 1 mM oligo(dT) primer and 4 U Omniscript RTase (Omniscript RT Kit; Qiagen, Mississauga, ON, Canada) according to the manufacturer's instructions.
Real-time PCR was conducted in an ABI Prism 7300 instrument (Applied Biosystems, Foster City, CA) with Power SYBR Green PCR Master Mix (Applied Biosystems) and bovine-specific primers for amplifying histone H2AFZ (sense: 5 0 -GAGGAGCTGAACAAGCTGTTG-3 0 ; anti-sense:
, cytochrome P450 cholesterol side-chain cleavage (CYP11A1), 3b-hydroxysteroid dehydrogenase (HSD3B1) and steroidogenic acute regulatory protein (STAR) [30] , 17b-hydroxysteroid dehydrogenase (HSD17B1) (sense: 340 PORTELA ET AL. [31] , FSH receptor (FSHR) [32] , and four genes known to function in cell proliferation and apoptosis that are upregulated in dominant compared to subordinate follicles in cattle: growth arrest and DNA-damage-inducible gene 45 b (GADD45B), cyclin D2 (CCND2), macrophage migration inhibitory factor (MIF), and replication factor C (activation 1) 4 (RFC4) [26] . Common thermal cycling parameters (3 min at 958C, 40 cycles of 15 sec at 958C, 30 sec at 608C, and 30 sec at 728C) were used to amplify each transcript. Melting curve analyses were performed to verify product identity. Samples were run in duplicate and were expressed relative to H2AFZ as housekeeping gene, which was expressed at similar levels (Ct values) in the granulosa and theca cell samples and was stable under the culture conditions used. Data were normalized to a calibrator sample using the DDCt method with correction for amplification efficiency [33] .
Steroid Assay
Estradiol was measured in follicle fluid and in conditioned medium in duplicate as described [34] , without solvent extraction. Intra-and interassay coefficients of variation were 6% and 9%, respectively. Progesterone was measured in conditioned medium in duplicate as described [35] with mean intra-and interassay coefficients of variation of 7.2% and 18%, respectively. The sensitivity of these assays was 10 pg and 4 pg per tube for estradiol and progesterone, equivalent to 0.3 and 20 ng/lg protein, respectively. Steroid concentrations in the culture medium were corrected for cell number by expressing the data per unit mass of total cell protein.
Statistics
Proportions of cells in stages of the cell cycle were arcsine transformed before the analysis. Other data that did not follow a normal distribution (Shapiro-Wilk test) were transformed to logarithms. Homogeneity of variance was tested with O'Brien and Brown-Forsythe tests. Analysis of variance was performed with JMP software (SAS Institute, Cary, NC) with the treatment as the main effect and culture replicate as a random variable in the F-test. Differences between means were tested with the Tukey-Kramer HSD (honestly significant difference) test (culture data) or paired t-test (in vivo data). Data are presented as means 6 SEM.
RESULTS
Real-time PCR revealed the presence of FGF18 mRNA predominantly in theca cells, weakly in granulosa, but not in oocytes (Fig. 1A) or intact COCs (not shown). FGF18 mRNA levels were significantly higher in atretic follicles compared with healthy follicles, and FGF18 mRNA levels did not vary with follicle size. Immunohistochemistry demonstrated the presence of FGF18 protein in the follicle and corpus luteum (Fig. 1, B-E) . Staining was observed in the granulosa and theca cell layers and in blood vessels. Little staining was observed in stromal tissue or in the presence of excess blocking peptide.
Because FGF18 was expressed in somatic cells rather than in germ cells, we assessed the role of gonadotropins and IGF1 in the regulation of FGF18 mRNA levels in vitro. In theca cells, physiological doses of LH did not alter FGF18 mRNA abundance, but 100 ng/ml LH increased FGF18 mRNA abundance compared with 0 and 1 ng/ml LH (Fig. 2) . In contrast to theca cells, FGF18 mRNA was not detectable in cultured granulosa cells irrespective of the dose of FSH or IGF1 used (Fig. 2) .
To explore the biological role of FGF18, granulosa cells were cultured in the presence of graded doses of FGF18 for 4 days. Estradiol and progesterone secretion were significantly inhibited in a dose-dependent manner (Fig. 3) . To determine the mechanism of suppression of steroid secretion, the abundance of mRNA encoding steroidogenic enzymes was measured in response to effective doses of FGF18. At doses that inhibited steroid secretion, FGF18 also lowered the concentration of mRNA encoding all the steroidogenic enzymes studied as well as those encoding STAR and FSHR (Fig. 3) . FGF18 also decreased the abundance of mRNA encoding another granulosa cell marker, SERPINE2, and decreased the secretion of the protein (Fig. 4) .
The inhibitory effect of FGF18 on steroidogenesis resembles what occurs in atretic follicles compared to dominant follicles, so we explored whether changes in FGF18 mRNA and protein levels accompany follicle atresia in vivo. Follicles were collected during the first follicle wave when the dominant follicle contained higher estradiol and CYP19A1 mRNA A) Real-time PCR of FGF18 mRNA in theca cells, granulosa cells, and oocytes of abattoir origin. Steady-state mRNA levels were expressed relative to a theca cell sample with the DDCt method. Follicles were classified as healthy (H, n ¼ 15), transitional (T, n ¼ 21), or atretic (A, n ¼ 7) based on E2:P ratios. Oocyte samples were three independent pools of .40 oocytes that gave robust housekeeping gene amplification. Immunohistochemical staining was observed in granulosa (g) and theca (t) cells of follicles (B) and in corpora lutea (cl; D). Weak background staining only was observed in stroma (s) or in the presence of excess blocking peptide (C and E). Photomicrographs were taken at 3200 magnification; bars ¼ 50 lm (B-E). Vertical bars in panel A without common letters are significantly different (P , 0.05); nd ¼ not detected.
FGF18 AND FOLLICLE ATRESIA concentration in granulosa cells compared with the next largest subordinate follicle (Fig. 5) . Abundance of FGF18 mRNA was higher in theca compared with granulosa cells and was significantly higher in subordinate follicles than in dominant follicles (Fig. 5D) . Follicular fluid FGF18 protein levels were correspondingly higher in subordinate follicles compared to dominant follicles (Fig. 5E ).
Fibroblast growth factors are known as mitogenic factors, yet cell proliferation decreases and apoptosis increases in subordinate follicles compared with dominant follicles, so we tested the effect of FGF18 on proliferation and the cell cycle in granulosa cells in vitro. FGF18 significantly altered progression of the cell cycle, causing a significant decrease in the proportion of cells in S phase and an increase in the proportion of cells appearing in the sub-G1 peak (Fig. 6A) . The proportion of cells in G2/M was increased 6% by FGF18, but this was not significant. Fractionation of DNA on agarose gels indicated an accumulation of fragmented DNA in FGF18-treated cells (Fig.  6B) although the number of cells at the end of the culture, measured with the MTT assay, was not altered by FGF18 (Fig.  6C) . FGF18 did not alter abundance of mRNA encoding CCND2, but reduced those encoding MIF, GADD45B, and RFC4 (Fig. 6D) .
DISCUSSION
FGF18 belongs to a subfamily of FGFs that includes FGF8 and FGF17, and all activate the same receptors [36] . Studies in mice and cattle have shown that FGF8 and FGF17 are expressed predominantly in oocytes [10, 11, 14, 15] . However, the results of the present study demonstrate that the pattern of FGF18 expression appears distinct from that of the other FGF8 subfamily members. Contrary to expectations, FGF18 mRNA was not detected in oocytes in cattle in the present study but was expressed predominantly in theca cells.
The lack of FGF18 mRNA in oocytes is intriguing. We analyzed mRNA from several pools of intact COCs and of denuded oocytes, and none generated amplicons after 40 cycles of real-time PCR. This is unlikely to be a methodological problem because the housekeeping gene H2AFZ was easily amplified in these samples and we have previously detected FGF8 and FGF17 mRNA in bovine oocytes [11, 14] . Abundance of FGF18 mRNA was reported to be high in mouse oocytes [15] ; therefore, there may be significant species differences in FGF18 expression in the ovary. It is unknown if FGF18 is expressed in oocytes of species other than mice.
To our knowledge, this is the first report of FGF18 mRNA in somatic cells of the ovary. In the present study, FGF18 mRNA was readily detectable in theca cells cultured under serum-free conditions but was not detectable in estrogenic granulosa cells cultured under similar conditions. These data suggest that theca cells are the predominant intrafollicular source of FGF18. This differs from FGF17, which appeared to be expressed at greater levels in granulosa cells compared with theca cells and for which mRNA was readily detected in granulosa cells cultured under the same conditions as used here [14] . FGF18 protein was detected in the follicle by immunohistochemistry, although the granulosa cell layer was stained as well as the theca cell layer. This is likely because FGF18 is a secreted protein, occurs in follicular fluid, and binds to its receptors on granulosa cells; receptor-bound FGFs have been shown to be internalized in several cell lines [37, 38] . The detection of FGF18 appears to be specific because preincubation of the antibody with blocking peptide abolished the staining, although we cannot rule out the possibility that the antibody reacts with other bovine FGFs.
Granulosa cells express receptors for FGF18 [11] , and FGF8 family members have been proposed as paracrine factors that signal to granulosa cells [13] . We therefore tested the direct effect of FGF18 on granulosa cell function in vitro. Secretion of estradiol and SERPINE2, both markers of healthy follicles [17, 27] , were inhibited by FGF18. The mechanism of this inhibition is most likely transcriptional because the abundance of SERPINE2, HSD17B1, and CYP19A1 mRNAs were also inhibited. These genes are responsive to FSH [20, 23, 39] , and their inhibition can be attributed to the observed reduction in FSHR mRNA abundance. Progesterone secretion was also inhibited by FGF18, and this was associated with decreased abundance of mRNA encoding the progestagenic proteins CYP11A1, HSD3B1, and STAR. This effect of FGF18 may not be mediated through a decrease in FSHR for although progesterone and CYP11A1 are stimulated by high doses of FSH [23] , the abundance of HSD3B1 mRNA is unaffected by   FIG. 2 . Regulation of FGF18 mRNA abundance in granulosa and theca cells in vitro. Granulosa and theca cells from 2-to 5-mm follicles were cultured under serum-free conditions for 6 days with LH (theca cells only) or with FSH or IGF1 (granulosa cells only) (see Materials and Methods for details). Steady-state mRNA levels were measured by real-time PCR and expressed relative to a calibrator sample with the DDCt method. Data are means 6 SEM of three independent cultures, and bars with no common letters are significantly different (P , 0.05); nd ¼ not detectable.
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FSH, and STAR mRNA is actually inhibited by FSH in this culture model [40] .
Inhibition of the estrogenic pathway is a characteristic of atretic follicles [17, 41] , and, therefore, FGF18 may play a role in atresia. If this is the case, changes in expression and/or secretion of FGF18 would be expected in atretic follicles compared with healthy follicles in vivo. To test this, we collected subordinate and dominant follicles during the first follicle wave and observed an increase in FGF18 mRNAparticularly in theca cells-in the subordinate follicles undergoing atresia, which was reflected by increased follicular fluid FGF18 protein content. A similar observation was made in follicles of abattoir origin, in which thecal FGF18 mRNA levels were highest in follicles classed as atretic based on the follicular fluid E2:P ratio. Combined, these data further suggest a link between FGF18 levels and follicle atresia. The stimulus for thecal FGF18 expression is unknown, although 100 ng/ml LH increased FGF18 mRNA levels in vitro. This is a supraphysiological dose as blood concentrations remain below 25 ng/ml even during the preovulatory LH surge [42, 43] and was used as it is one of few hormonal treatments known to induce apoptosis in theca cells [44] . The expression of some other FGFs is increased in atretic follicles, including FGF17 [14] , but this is not a general effect as thecal FGF7 mRNA abundance did not differ between estrogenic and nonestrogenic bovine follicles and FGF2 mRNA was reduced in atretic follicles in rats [6, 45] .
Atresia of bovine follicles is associated with reduced proliferation and increased death of granulosa cells, which may be through apoptotic or nonapoptotic pathways [46] [47] [48] , and with decreased expression of the cell cycle regulator GADD45B and the cell proliferation-associated genes MIF and RFC4 [26] . In the present study, FGF18 altered cell cycle progression by decreasing the number of cells in S phase, and this was accompanied by an increase in the proportion of dead cells (the sub-G1 peak [49] ). The increase in the number of dead cells was supported by an increase in DNA fragmentation in FGF18-treated cells. Although FGFs are mitotic in many if not most cells types, antiproliferative and proapoptotic actions have been reported in some cells lines [50] . For example, FGF1 and FGF2 have been reported to induce cell cycle arrest in chondrocytes [51, 52] and neuroblastoma cells [53, 54] , FGF2 promoted apoptosis in differentiating osteoblasts [55] , and FGF18 decreased proliferation of intestinal crypt cells [56] . This action of FGF18 on the cell cycle appears novel in the ovary; in contrast, FGF2 and FGF7 inhibited steroidogenesis in granulosa cells while preventing apoptosis [7, [57] [58] [59] [60] [61] . It is not   FIG. 3 . Effect of FGF18 on secretion of estradiol from bovine granulosa cells and on steady-state levels of mRNA encoding proteins critical for estradiol biosynthesis (upper row) and on progesterone secretion and concentration of mRNA-encoding proteins involved in progesterone biosynthesis (lower row). Granulosa cells from 2-to 5-mm follicles were cultured in serum-free medium containing FSH (10 ng/ml) for 6 days and treated with the stated doses of FGF18 for the last 4 days of culture. Steady-state mRNA levels were measured by real-time PCR and expressed relative to a calibrator sample with the DDCt method. Data are means 6 SEM of three independent cultures, and bars with no common letters are significantly different (P , 0.05).
FIG. 4.
Effect of FGF18 on secretion of SERPINE2 protein and abundance of SERPINE2 mRNA in granulosa cell culture. Granulosa cells from 2-to 5-mm follicles were cultured in serum-free medium containing FSH (10 ng/ml) for 6 days and treated with the stated doses of FGF18 for the last 4 days of culture. Steady-state mRNA levels were measured by real-time PCR and expressed relative to a calibrator sample with the DDCt method. Protein secretion was measured by a Western blot of the culture medium, and blots of two independent cultures are shown with the samples in the same order as in the graph. Data are means 6 SEM of three independent cultures, and bars with no common letters are significantly different (P , 0.05).
FGF18 AND FOLLICLE ATRESIA known at this point whether the action of FGF18 is direct or mediated through other factors that can induce apoptosis in granulosa cells, such as androgens (reviewed in [62] ).
FGF18 decreased the abundance of GADD45B mRNA in granulosa cells in vitro (present study), and GADD45 proteins have been identified as cell cycle checkpoint regulators in several cell lines [63, 64] . Of relevance to the present results, an increase in GADD45 proteins has been associated with an increased number of colon cancer cells in S phase [65] , and decreased GADD45B expression was associated with an increase in the number of hepatocellular carcinoma cells in the sub-G1 peak [66] . The present observation of decreased GADD45B mRNA levels in FGF18-treated cells provides an explanation for the increase in dead cells and the decrease in Sphase cells. The only other study linking FGF and GADD45-mediated cell proliferation is a microarray study in a chondrocyte cell line in which FGF1 rapidly and transiently increased GADD45B mRNA levels coincident with transient G2/M-phase arrest [51] . This is not entirely consistent with the present results, and the difference between the studies is likely owing to the very different nature of the cells because granulosa cells cultured in serum-free conditions differentiate rather than proliferate [19, 39] . It is recognized that GADD45 proteins may have proliferative or apoptotic actions depending on the cell type [67] . FGF18 also inhibited MIF mRNA accumulation in the present study. We are not aware of other studies linking FGFs to MIF expression, but it is interesting to note that silencing of MIF in HEK293 cells leads to significant decrease in GADD45B mRNA levels [68] . It is therefore   FIG. 5 . FGF18 mRNA and protein abundance in granulosa cells and theca cells in healthy dominant (DF) and in subordinate (SF) follicles during emergence of a follicular wave. Follicles were collected from five cows when the follicles were of similar diameter (A) but differed in estradiol concentration in the follicular fluid (B) and CYP19 mRNA abundance in granulosa cells (C). D) Steady-state FGF18 mRNA levels were measured by real-time PCR and expressed relative to a calibrator sample with the DDCt method. E) FGF18 protein levels in follicular fluid were measured by Western blot (blots are shown for four animals). Data are means 6 SEM, and asterisks denote significant differences between DF and SF (*P , 0.05, **P , 0.01).
FIG. 6. Effect of FGF18 on proliferation and the cell cycle. Granulosa cells were cultured in serum-free medium containing FSH (10 ng/ml) for 6 days and treated with FGF18 for the last 4 days of culture. A) The proportion of cells in sub-G1 (light gray bars), G0/1 (white bars), S (dark gray bars), and G2/M (black bars) phases where measured by flow cytometry. B) DNA fragmentation by gel electrophoresis. C) Proliferation measured by the MTT assay. D) Relative abundance of mRNA encoding four cell proliferation and death genes was measured by real-time PCR. Data are means 6 SEM of three independent cultures, and bars with no common letters are significantly different (P , 0.05). Asterisks identify cell-cycle stages significantly affected by FGF18 (A).
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possible that the FGF18 inhibition of GADD45B mRNA levels is mediated through a reduction in MIF levels.
In summary, the results of the present study point to a novel role for FGF18 in follicle growth. One scenario of FGF18 action during follicle selection is as follows. At the beginning of a follicle wave, FSH drives the growth of the cohort of follicles and also stimulates expression of the major granulosa FGF18 receptor, FGFR3C [11] , making granulosa cells susceptible to FGF action. Theca cells are the main source of follicular FGF18, and in the subordinate follicle, an unidentified trigger increases thecal secretion of FGF18, which in turn acts on granulosa cells to inhibit steroidogenesis, decrease the expression of cell survival/proliferation genes, and alter progression through the cell cycle, resulting in atresia. In dominant follicles, the atretic stimulus does not occur, thecal FGF18 secretion remains low, and the follicle continues to grow.
